Prevention, investigation and management of venous thromboembolism and antithrombotics: indications and management

ClotCare: Blood Clots, Stroke, Heart Attack

Thursday, November 21, 2024

Home | DVT/PE | Blood Clots | Coumadin/Warfarin | New Patients | Self Testing | Email List | Donate

Pick a Topic: Home New Postings Patient Postings Clinician Postings Join Our Email List Useful Web Links CE Opportunities Training Programs Guidelines DVT & PE Stories Editorial Board Financial Support About ClotCare DVT Coalition Contact Us Find info on a: Specific Medicine or Treatment Type of Medicine or Treatment Condition or Medical Procedure Lab Test Procedure Management Issue ClotCare complies with the HONcode standard for trustworthy health information: verify here. ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.	Scotland: Prevention, investigation and management of venous thromboembolism and antithrombotics: indications and management Presented by: Scottish Intercollegiate Guidelines Network Part of NHS Quality Improvement Scotland When: September 29, 2009 Developments in the prevention and management of thrombosis have had an impact on the clinical care delivered by healthcare professionals across a wide range of specialties. The associated health gains have been accompanied by increased complexity in the prevention and management of thrombosis. Drafts of updated SIGN guidelines will be presented for discussion at a joint national open meeting on the 29th September, 2009. The open meeting will be of particular relevance to anaesthetists, cardiologists, dentists, general and specialist physicians, general and specialist surgeons, general practitioners, haematologists, nurses, obstetricians, pharmacists and radiologists. It will also be of interest to patients and members of the voluntary sector. SIGN guidelines are developed by multidisciplinary guideline development groups with representation from across Scotland. The guideline recommendations are based on a systematic review of evidence on effective management of the clinical condition concerned and full consultation with healthcare practitioners in all relevant disciplines. The national guidelines are disseminated throughout NHSScotland and are then tailored and implemented according to local circumstances for the benefit of patients. You can download the program brochure and registration form at www.sign.ac.uk/events/vte.html.	Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org. ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters. New Postings: Click here to view full list of new postings
ClotCare Home \| New Postings \| Patient Postings \| Clinician Postings \| Join Our Email List \| Useful Web Links CE Opportunities \| Training Programs \| DVT & PE Stories \| Editorial Board \| Financial Support About ClotCare \| DVT Coalition \| Donate to ClotCare \| Contact Us
Key topics discussed on ClotCare include: Blood Clots \| Deep Vein Thrombosis (DVT) \| Pulmonary Embolism (PE) \| Atrial Fibrillation (A. Fib or AF) \| Heart Attack \| Stroke \| Transient Ischemic Attack (TIA) \| Mini Stroke \| Bleeding Complications \| Vascular Surgery \| Surgical Blood Clot Removal \| Warfarin \| Coumadin \| Lovenox \| Low Molecular Weight Heparin (LMWH) \| Heparin \| Anticoagulants \| Plavix \| Aspirin \| Antiplatelets \| Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved. Terms, Conditions, & Privacy \| Image Copyright Information 19260 Stone Oak Parkway, Suite 101 \| San Antonio, TX 78258 \| 210-860-0487 Send comments to webmaster@clotcare.org. Thursday, November 21, 2024